An analysis of data on 80,241 patients with acute coronary syndrome who participated in a heart disease program from January 2005 to December 2009 showed that almost 1 in 5 eligible patients did not receive angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at hospital discharge despite recommendations from the American College of Cardiology and American Heart Association. The prescription rate for the drugs rose from 76.7% to 84.6% over the study period. The findings appear in the journal Circulation: Cardiovascular Quality and Outcomes.

Related Summaries